₹1.00
(Market cap
₹19 Cr
Recently Viewed
Clear AllMarket cap
₹19 Cr
Revenue (TTM)
₹7 Cr
P/E Ratio
64.4
P/B Ratio
1.5
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
4.9 %
ROCE
6.7 %
Industry P/E
33.96
EV/EBITDA
23.9
Debt to Equity
0.3
Book Value
₹10.1
EPS
₹0.3
Face value
10
Shares outstanding
8,712,000
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hamps Bio
| 10.0 | 25.7 | 17.3 | 7.2 | -- | -- | -- |
|
BSE Healthcare
| -1.9 | -1.8 | -2.4 | 7.7 | 24.3 | 13.4 | 10.8 |
|
Company
|
2025
|
|---|---|
|
Hamps Bio
| -49.6 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hamps Bio
|
22.0 | 19.2 | 6.7 | 0.3 | -- | 4.9 | 64.4 | 1.5 |
| 820.0 | 1,533.8 | 77.0 | 16.4 | -- | 43.4 | 97.1 | 14.3 | |
| 1,741.9 | 28,914.8 | 6,112.8 | 847.2 | 17.2 | 9.2 | 34.1 | 2.9 | |
| 126.5 | 41.8 | 13.9 | 0.4 | -- | 5.6 | 94.9 | 5.2 | |
| 190.1 | 1,035.5 | 264.6 | 19.3 | 8.9 | 6.2 | 44.7 | 4.5 | |
| 866.9 | 10,374.5 | 6,537.7 | 207.0 | 4.6 | 11.5 | 50.1 | 5.5 | |
| 40.1 | 70.3 | 167.8 | 5.9 | -- | 5.7 | 12 | 0.7 | |
| 35.1 | 58.9 | 62.0 | 5.0 | -- | 12.2 | 11.9 | 1.1 | |
| 175.0 | 93.6 | 61.7 | 6.3 | -- | 28.9 | 14.8 | 3.0 | |
| 138.0 | 51.7 | 20.6 | 2.5 | 18.7 | 16.9 | 20.8 | 3.0 |
No Review & Analysis are available.
--
Incorporated
2007
Chairman
Herrik Shah
Managing Director
Herrik Shah
Headquarters
Bharuch, Gujarat
Website
Looking for more details about Hamps Bio Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Hamps Bio Ltd is ₹22.00 (BSE) as of 10-Apr-2026 IST. Hamps Bio Ltd has given a return of 7.19% in the last 1 years.
The P/E ratio of Hamps Bio Ltd is 64.38 times as on 10-Apr-2026, a 90 premium to its peers’ median range of 33.96 times.
The P/B ratio of Hamps Bio Ltd is 1.46 times as on 10-Apr-2026, a 44 discount to its peers’ median range of 2.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
62.55
|
2.12
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
62.55
|
2.12
|
The 52-week high and low of Hamps Bio Ltd are Rs 35.00 and Rs 13.36 as of 10-Apr-2026.
Hamps Bio Ltd has a market capitalisation of ₹ 19 Cr as on 10-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Hamps Bio Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.